We came across a bullish thesis on Biogen Inc. on r/Valueinvesting subreddit by U/Lobyous. In this article, we will summarize the bulls’ thesis on BIIB. Biogen Inc.’s share was trading at $131.52 as of July 25th. BIIB’s trailing and forward P/E were 13.00 and 8.85 respectively according to Yahoo Finance.
A scientist in a lab, researching for a breakthrough treatment for Alzheimer’s disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1 Diabetes.
Biogen (BIIB) remains deeply...
